The potential of utrophin and dystrophin combination therapies for Duchenne muscular dystrophy
S Guiraud, B Edwards, A Babbs… - Human Molecular …, 2019 - academic.oup.com
Duchenne muscular dystrophy (DMD) is a lethal neuromuscular disorder caused by loss of
dystrophin. Several therapeutic modalities are currently in clinical trials but none will achieve …
dystrophin. Several therapeutic modalities are currently in clinical trials but none will achieve …
Utrophin upregulation for treating Duchenne or Becker muscular dystrophy: how close are we?
Duchenne muscular dystrophy (DMD) is a severe muscle-wasting disorder for which there is
currently no effective treatment. This disorder is caused by mutations or deletions in the …
currently no effective treatment. This disorder is caused by mutations or deletions in the …
Therapeutic strategies for Duchenne and Becker dystrophies
V Voisin, S de La Porte - Int Rev Cytol, 2004 - books.google.com
Duchenne muscular dystrophy (DMD), a severe X-linked genetic disease affecting one in
3500 boys, is the most common myopathy in children. DMD is due to a lack of dystrophin, a …
3500 boys, is the most common myopathy in children. DMD is due to a lack of dystrophin, a …
Alternative utrophin mRNAs contribute to phenotypic differences between dystrophin‐deficient mice and Duchenne muscular dystrophy
KJ Perkins, KE Davies - FEBS letters, 2018 - Wiley Online Library
Duchenne muscular dystrophy (DMD) is a fatal disorder caused by absence of functional
dystrophin protein. Compensation in dystrophin‐deficient (mdx) mice may be achieved by …
dystrophin protein. Compensation in dystrophin‐deficient (mdx) mice may be achieved by …
Molecular, cellular, and pharmacological therapies for Duchenne/Becker muscular dystrophies
JV Chakkalakal, J Thompson, RJ Parks… - The FASEB …, 2005 - Wiley Online Library
Although the molecular defect causing Duchenne/Becker muscular dystrophy (DMD/BMD)
was identified nearly 20 years ago, the development of effective therapeutic strategies has …
was identified nearly 20 years ago, the development of effective therapeutic strategies has …
Utrophin modulator drugs as potential therapies for Duchenne and Becker muscular dystrophies
P Soblechero‐Martín, A López‐Martínez… - Neuropathology and …, 2021 - Wiley Online Library
Utrophin is an autosomal paralogue of dystrophin, a protein whose deficit causes Duchenne
and Becker muscular dystrophies (DMD/BMD). Utrophin is naturally overexpressed at the …
and Becker muscular dystrophies (DMD/BMD). Utrophin is naturally overexpressed at the …
Non-toxic ubiquitous over-expression of utrophin in the mdx mouse
R Fisher, JM Tinsley, SR Phelps, SE Squire… - Neuromuscular …, 2001 - Elsevier
Duchenne muscular dystrophy (DMD) is an inherited, severe muscle wasting disease
caused by the loss of the cytoskeletal protein, dystrophin. Patients usually die in their late …
caused by the loss of the cytoskeletal protein, dystrophin. Patients usually die in their late …
Utrophin upregulation in Duchenne muscular dystrophy.
RC Hirst, KJ McCullagh, KE Davies - Acta myologica: myopathies …, 2005 - europepmc.org
Duchenne Muscular Dystrophy (DMD) is a devastating, progressive muscle wasting disease
for which there is currently no effective treatment. DMD is caused by mutations in the …
for which there is currently no effective treatment. DMD is caused by mutations in the …
The role of utrophin in the potential therapy of Duchenne muscular dystrophy
KJ Perkins, KE Davies - Neuromuscular disorders, 2002 - Elsevier
Duchenne muscular dystrophy is an X-linked recessive muscle wasting disease caused by
the absence of the muscle cytoskeletal protein, dystrophin. Dystrophin is a member of the …
the absence of the muscle cytoskeletal protein, dystrophin. Dystrophin is a member of the …
Duchenne muscular dystrophy drug discovery–the application of utrophin promoter activation screening
C Moorwood, TS Khurana - Expert Opinion on Drug Discovery, 2013 - Taylor & Francis
Introduction: Duchenne muscular dystrophy (DMD) is a devastating genetic muscle wasting
disease caused by mutations in the DMD gene that in turn lead to an absence of dystrophin …
disease caused by mutations in the DMD gene that in turn lead to an absence of dystrophin …